Aromyx

Aromyx was a biotechnology company in Mountain View, California, that measured and digitized taste and smell. Its platform used human smell and taste receptors, which activate when exposed to an odor or flavor sample placed on the company's biosensors; the resulting receptor activation patterns were decoded to characterize a sample, for example whether it was pleasant, contaminated or toxic. The company's product was identified as the EssenceChip, which translated chemical interactions into digital sensory profiles.

Receptor test data was fed into Aromyx's cloud software and AI programs for comparison, modeling, simulation and interpretation, producing indicators used for supply-chain optimization, quality control measures, product reformulation and new product development. The company also positioned its data for market-facing uses, including genetic and demographic mapping to assess which products appeal to particular regions and populations, identification of new customer segments and consumer targeting. Stated customer benefits spanned sustainability, new product development, quality, cost reduction and health.

Aromyx said its partners applied olfaction technology in areas including disease diagnostics, plant-based food innovation, and optimization of fermentation and recycled-plastics processes. A blog post published by competitor Ajinomatrix subsequently referred to the closure of Aromyx, attributing the outcome to the difficulty of monetizing pioneering sensory technology amid a contraction in food and beverage product launches and broader investment slowdown.

Founding story

A third-party company profile states that Aromyx was founded in 2013 by William Harries, who was previously associated with StartX (the Stanford-StartX Fund), and that the company was built in Mountain View to exploit human olfactory receptors as a means of generating objective sensory data.

Business model

Aromyx sold sensory measurement as a service and data platform: customers submitted odor or flavor samples for receptor-based testing, and the resulting data was delivered through the company's cloud software for comparison, modeling, simulation and interpretation. Engagements included custom, collaborative projects intended to integrate insights into a customer's product development and quality-control workflows.

Revenue derived from business customers commissioning receptor-based sensory testing and the associated software, data and custom insight deliverables; specific pricing terms are not disclosed.

Traction

Aromyx stated it served innovative startups and Fortune 500 companies across industries, with partners applying its olfaction technology in disease diagnostics, plant-based foods, fermentation optimization and recycled plastics processing. A third-party profile reported that the company had raised a Series A round but noted that specific financial details were not public.

Latest developments

A post on the website of competitor Ajinomatrix discussed the closure of Aromyx, describing it as the shutdown of a sensory technology company whose "artificial perception" work had supported food makers in preserving flavor while reformulating ingredients, and framing the outcome against reduced food and beverage product launches and a wider market downturn.